Antioxidant and renoprotective effects of sphingosylphosphorylcholine on contrast-induced nephropathy in rats

References

• James MT, Samuel SM, Manning MA, et al. Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: A systematic review and meta-analysis. Circ Cardiovasc Interv. 2013;6:37–43.
   PubMed Web of Science ®Google Scholar
• Okoye O, Ojogwu L, Unuigbe E, Oviasu E. Frequency and risk factors of contrast-induced nephropathy after contrast procedures in a Nigerian tertiary centre. West Afr J Med. 2013;32:19–25.
   PubMedGoogle Scholar
• Thomsen HS, Morcos SK. Contrast media and the kidney: European society of urogenital radiology (ESUR) guidelines. Br J Radiol. 2003;76:513–518.
   PubMed Web of Science ®Google Scholar
• Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: State of the art. Nephrol Dial Transplant. 2005;20:1542–1550.
   PubMed Web of Science ®Google Scholar
• Wang F, Li J, Huang B, et al. Clinical survey on contrast-induced nephropathy after coronary angiography. Ren Fail. 2013;35:1255–1259.
   PubMed Web of Science ®Google Scholar
• Sanadgol H, Abdani S, Tabatabaiee P, Mohammadi M. Protective effect of high dose short term statin therapy with normal saline in prevention of contrast-induced nephropathy among iodixanol-receiving patients. J Ren Inj Prev. 2012;1:43–45.
   PubMedGoogle Scholar
• Kwok CS, Pang CL, Yeong JK, Loke YK. Measures used to treat contrast-induced nephropathy: Overview of reviews. Br J Radiol. 2013;86:20120272.
   PubMed Web of Science ®Google Scholar
• Haeussler U, Riedel M, Keller F. Free reactive oxygen species and nephrotoxicity of contrast agents. Kidney Blood Press Res. 2004;27:167–171.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Lass N, Gaber AO. Radiocontrast mediuminduced declines in renal function: A role for oxygen free radicals. Am J Physiol. 1990;258:115–120.
   PubMed Web of Science ®Google Scholar
• Yagmurlu A, Aksu B, Bingol-Kologlu M, et al. A novel approach for preventing esophageal stricture formation: Sphingosylphosphorylcholine-enhanced tissue remodeling. Pediatr Surg Int. 2004;20:778–782.
   PubMed Web of Science ®Google Scholar
• Higuchi K, Kawashima M, Ichikawa Y, Imokawa G. Sphingosylphosphorylcholine is a melanogenic stimulator for human melanocytes. Pigment Cell Res. 2003;16:670–678.
   PubMedGoogle Scholar
• Mulders AC, Nau S, Li Y, Michel MC. Effects of sphingosine-1-phosphate and sphingosylphosphorylcholine on intracellular Ca2+ and cell death in prostate cancer cell lines. Auton Autacoid Pharmacol. 2007;27:173–179.
   PubMedGoogle Scholar
• Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta. 2002;1582:81–88.
   PubMed Web of Science ®Google Scholar
• Murch O, Abdelrahman M, Collino M, et al. Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat. Crit Care Med. 2008;36:550–559.
   PubMed Web of Science ®Google Scholar
• Jeon ES, Kang YJ, Song HY, et al. Sphingosylphos-phorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways. Cell Signal. 2005;17: 777–787.
   PubMed Web of Science ®Google Scholar
• Huwiler A, Pfeilschifter J. Lipids as targets for novel anti-inflammatory therapies. Pharmacol Ther. 2009;124:96–112.
   PubMed Web of Science ®Google Scholar
• Aksu B, Umit H, Kanter M, et al. Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats. J Pediatr Surg. 2009;44:702–710.
   PubMed Web of Science ®Google Scholar
• Zhang H, Buckley NE, Gibson K, Spiegel S. Sphingosine stimulates cellular proliferation via a protein kinase C-independent pathway. J Biol Chem. 1990;265:76–81.
   PubMed Web of Science ®Google Scholar
• Lenhard DC, Pietsch H, Sieber MA, et al. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety. Invest Radiol. 2012;47:503–510.
   PubMed Web of Science ®Google Scholar
• Sun Y, Oberley LW, Li YA. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497–500.
   PubMed Web of Science ®Google Scholar
• Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 1982;126:131–138.
   PubMed Web of Science ®Google Scholar
• Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302–310.
   PubMedGoogle Scholar
• Aksu B, Ayvaz S, Aksu F, et al. Effects of sphingosylphosphorylcholine against oxidative stress and acute lung injury induced by pulmonary contusion in rats. J Pediatr Surg. 2015;50:591–597.
   PubMed Web of Science ®Google Scholar
• Briguori C, Tavano D, Colombo A. Contrast agent-associated nephrotoxicity. Prog Cardiovasc Dis. 2003;45:493–503.
   PubMed Web of Science ®Google Scholar
• Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol. 2000;11:177–182.
   PubMed Web of Science ®Google Scholar
• Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy: A role for medullary hypoxia. Invest Radiol. 1999;34:685–691.
   PubMed Web of Science ®Google Scholar
• Morcos SK, Thomsen HS, Exley CM, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Contrast media: Interactions with other drugs and clinical tests. Eur Radiol. 2005;15:1463–1468.
   PubMed Web of Science ®Google Scholar
• Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Intern. 2005;68:14–22.
   PubMed Web of Science ®Google Scholar
• Kurtoglu T, Durmaz S, Akgullu C, et al. Ozone preconditioning attenuates contrast-induced nephropathy in rats. J Surg Res. 2015;195:604–611.
   PubMed Web of Science ®Google Scholar
• Aurelio A, Durante A. Contrast-induced nephropathy in percutaneous coronary interventions: Pathogenesis, risk factors, outcome, prevention and treatment. Cardiology. 2014;128:62–72.
   PubMed Web of Science ®Google Scholar
• Jeon ES, Lee MJ, Sung SM, Kim JH. Sphingosylphosphorylcholine induces apoptosis of endothelial cells through reactive oxygen species-mediated activation of ERK. J Cell Biochem. 2007;100:1536–1547.
   PubMed Web of Science ®Google Scholar
• Jeon ES, Kang YJ, Song HY, et al. Role of MEK-ERK pathway in sphingosylphosphorylcholine-induced cell death in human adipose tissue-derived mesenchymal stem cells. Biochim Biophys Acta. 2005;1734:25–33.
   PubMed Web of Science ®Google Scholar
• Desai NN, Carlson RO, Mattie ME, et al. Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. J Cell Biol. 1993;121:1385–1395.
   PubMed Web of Science ®Google Scholar
• Wong PC, Li Z, Guo J, Zhang A. Pathophysiology of contrast-induced nephropathy. Int J Cardiol. 2012;158:186–192.
   PubMed Web of Science ®Google Scholar
• Quintavalle C, Brenca M, De Micco F, et al. In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. Cell Death Dis. 2011;2:155.
   PubMed Web of Science ®Google Scholar
• Romano G, Briguori C, Quintavalle C, et al. Contrast agents and renal cell apoptosis. Eur Heart J. 2008;29:2569–2576.
   PubMed Web of Science ®Google Scholar
• Mogami K, Mizukami Y, Todoroki-Ikeda N, et al. Sphingosylphosphorylcholine induces cytosolic Ca2+ elevation in endothelial cells in situ and causes endothelium-dependent relaxation through nitric oxide production in bovine coronary artery. FEBS Lett. 1999;457:375–380.
   PubMed Web of Science ®Google Scholar
• Todoroki-Ikeda N, Mizukami Y, Mogami K, et al. Sphingosylphosphorylcholine induces Ca(21)-sensitization of vascular smooth muscle contraction: Possible involvement of rho-kinase. FEBS Lett. 2000;482:85–90.
   PubMed Web of Science ®Google Scholar
• Dantas AP, Igarashi J, Michel T. Sphingosine 1-phosphate and control of vascular tone. Am J Physiol Heart Circ Physiol. 2003;28:2045–2052.
   Web of Science ®Google Scholar
• Watterson KR, Ratz PH, Spiegel S. The role of sphingosine-1-phosphate in smooth muscle contraction. Cell Signal. 2005;17:289–298.
   PubMed Web of Science ®Google Scholar
• Nofer JR, van der Giet M, Tölle M, et al. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest. 2004;113:569–581.
   PubMed Web of Science ®Google Scholar
• Meyer zu Heringdorf D, Himmel HM, Jakobs KH. Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochim Biophys Acta. 2002;1582:178–189.
   PubMed Web of Science ®Google Scholar
• Nixon GF, Mathieson FA, Hunter I. The multi-functional role of sphingosylphosphorylcholine. Prog Lipid Res. 2008;47:62–75.
   PubMed Web of Science ®Google Scholar
• Xin C, Ren S, Eberhardt W, Pfeilschifter J, Huwiler A. Sphingosylphosphorylcholine acts in an anti-inflammatory manner in renal mesangial cells by reducing interleukin-1beta-induced prostaglandin E2 formation. J Lipid Res. 2007;48:1985–1996.
   PubMed Web of Science ®Google Scholar
• Thomas DD, Espey MG, Ridnour LA, et al. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci U S A. 2004;101:8894–8899.
   PubMed Web of Science ®Google Scholar
• Hannibal L. Nitric oxide homeostasis in neurodegenerative diseases. Curr Alzheimer Res. 2016;13:135–149.
   PubMed Web of Science ®Google Scholar
• Ulusoy S, Ozkan G, Mungan S, et al. GSPE is superior to NAC in the prevention of contrast-induced nephropathy: Might this superiority be related to caspase 1 and calpain 1? Life Sci. 2014;103:101–110.
   PubMed Web of Science ®Google Scholar
• Nofer JR, Levkau B, Wolinska I, et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem. 2001;276:34480–34485.
   PubMed Web of Science ®Google Scholar
• Gong X, Wang Q, Tang X, et al. Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways. Am J Nephrol. 2013;37:199–207.
   PubMed Web of Science ®Google Scholar